Kaysen Martin needs a life-saving gene therapy for spinal muscular atrophy Type 1 (SMA 1). Zolgensma costs $2.8 million and has to be administered before his second birthday — which is tomorrow. Nicole Stillger has this update on the push to pay for the drug.
Global News at Noon Edmonton
Baby Kaysen update on push to raise $2.8M for life-saving gene therapy
More Videos
-
Study finds brawn does not mean brains when it comes to the T.Rex
-
It’s opening day for the $34B Trans Mountain oil pipeline expansion
-
Alberta Municipalities ‘caught off guard’ by details of Bill 20
-
Mitigating fire risk in Edmonton
-
Edmonton special Olympic athlete chosen in local advertising campaign
-
Education minister highlights changes in new draft of social studies curriculum
You are viewing an Accelerated Mobile Webpage.
View Original Article